Hydroxychloroquine stock to be monitored on IT platform: NPPA

According to officials, the center government’s department of pharmaceuticals is developing a platform that would be run by information technology (IT) to monitor the stock of anti-malaria drug hydroxychloroquine (HCQ) after allegations of supply crunch in several places.

However, pharma players said there is no shortage of hydroxychloroquine, which is used as a prophylaxis (a treatment to prevent a disease) for people at high risk of contracting the coronavirus disease (Covid-19). They also said that tbe reports of shortages could be attributed to a popular brand running out of stock because of hoarding by patients.

NPPA and the Drugs Controller of India under the health ministry, have approached all stakeholders to have a check upon the information on the supply of the medicine is uploaded and updated on the platform on a regular basis. This will help officials updated on the medicine’s availability and address gaps as and when they surface.

Basant Goel, the president of Retailers and Distributors Chemist Association (RDCA), said that, “there is a particular brand that is facing supply shortage though others are available in the market.The initial shortage was reported because, when there was no restriction on the sale of hydroxychloroquine, people started hoarding a popular brand. But now we will be getting more supplies. Also, the sale of hydroxychloroquine is restricted by the governemnt, and you need to have a valid prescription to buy it.”

Earlier, over-the-counter sale of hydroxychloroquine was already restricted by the government. It is now available only on prescription. While health ministry says all departments are taking extra steps to ensure the supply of hydroxychloroquine, the external affairs maintains that only the surplus stock is being exported after the recent relaxations of rules.

“We have adequate manufacturing capacity, today, in the country and have sufficient supply to meet both domestic and export demand,” the Indian Pharmaceutical Alliance said in a statement.

  • Related Posts

    • Health
    • February 10, 2024
    • 11 views
    Appointment of CEO packs a Punch in NeuroEqulibrium’s Global Goal

    New Delhi: The ambition of NeuroEquilibrium gets a shot in the arm with the appointment of industry vetran Samit Verma as its CEO (Chief Executive Officer). Its global aspiration will…

    Millets reigned Supreme in International Symposium on Gut Health

    New Delhi: Millets reign supreme as gut health assumes most important aspect of the latest preventive and curative healthcare approach. This fact was writ large on Symposium on ‘Gut Health…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Lee Health develops natural capsule for effective Heart care

    Lee Health develops natural capsule for effective Heart care

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down